Literature DB >> 22687661

Chronic catatonia with obsessive compulsive disorder symptoms treated with lorazepam, memantine, aripiprazole, fluvoxamine and neurosurgery.

Yuki Mukai1, Aimee Two, Michel Jean-Baptiste.   

Abstract

Catatonia is a syndrome with protean manifestations and multiple aetiologies. In this report, the authors describe the case of a young woman who presented for care after a 13-year period of catatonia-like symptoms, including mutism, refusal to eat and persistent neck flexion. Medical management included placement of a percutaneous endoscopic gastric tube for nutritional support. A thorough medical investigation later revealed the presence of a cervical spine haemangioma that was treated surgically, with improvement in neck posturing. Psychopharmacological treatment included lorazepam, aripiprazole and memantine. Addition of fluvoxamine to target obsessive compulsive disorder (OCD)-like symptoms resulted in clinical improvement, suggesting OCD as a possible cause of this patient's chronic catatonic state.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22687661      PMCID: PMC4545093          DOI: 10.1136/bcr.02.2011.3858

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  7 in total

Review 1.  Towards a valid nosography and psychopathology of catatonia in children and adolescents.

Authors:  David Cohen
Journal:  Int Rev Neurobiol       Date:  2006       Impact factor: 3.230

Review 2.  Understanding obsessive-compulsive disorder: focus on decision making.

Authors:  Paolo Cavedini; Alessandra Gorini; Laura Bellodi
Journal:  Neuropsychol Rev       Date:  2006-03       Impact factor: 7.444

3.  Catatonia in obsessive-compulsive disorder: etiopathogenesis, differential diagnosis, and clinical management.

Authors:  Leonardo F Fontenelle; Edward C Lauterbach; Leonardo L Telles; Marcio Versiani; Fábio H Porto; Mauro V Mendlowicz
Journal:  Cogn Behav Neurol       Date:  2007-03       Impact factor: 1.600

4.  Memantine augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trial.

Authors:  Elias Aboujaoude; John J Barry; Nona Gamel
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

Review 5.  Catatonia: a review.

Authors:  Natalie D Weder; Sunanda Muralee; Heath Penland; Rajesh R Tampi
Journal:  Ann Clin Psychiatry       Date:  2008 Apr-Jun       Impact factor: 1.567

Review 6.  Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes.

Authors:  Brendan T Carroll; Harold W Goforth; Christopher Thomas; Niraj Ahuja; William W McDaniel; Marilyn F Kraus; David R Spiegel; Kathleen N Franco; Leopold Pozuelo; Camilo Muñoz
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

Review 7.  What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis.

Authors:  Georg Northoff
Journal:  Behav Brain Sci       Date:  2002-10       Impact factor: 12.579

  7 in total
  4 in total

1.  Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia.

Authors:  Marie Raffin; Laetitia Zugaj-Bensaou; Nicolas Bodeau; Vanessa Milhiet; Claudine Laurent; David Cohen; Angèle Consoli
Journal:  Eur Child Adolesc Psychiatry       Date:  2014-08-27       Impact factor: 4.785

Review 2.  Memantine: New prospective in bipolar disorder treatment.

Authors:  Giulia Serra; Francesca Demontis; Francesca Serra; Lavinia De Chiara; Andrea Spoto; Paolo Girardi; Giulio Vidotto; Gino Serra
Journal:  World J Psychiatry       Date:  2014-12-22

Review 3.  Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence.

Authors:  Daniel Felipe Ariza-Salamanca; María Gabriela Corrales-Hernández; María José Pachón-Londoño; Isabella Hernández-Duarte
Journal:  Front Mol Neurosci       Date:  2022-09-29       Impact factor: 6.261

4.  Chronic catatonia treated with electroconvulsive therapy: a case report.

Authors:  Varuni A de Silva; Wickramaarachchige D Lakmini; Heshan N Gunawardena; Raveen Hanwella
Journal:  J Med Case Rep       Date:  2013-08-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.